Atea Pharmaceuticals Inc. (AVIR): Price and Financial Metrics
AVIR Price/Volume Stats
| Current price | $3.37 | 52-week high | $4.60 |
| Prev. close | $3.33 | 52-week low | $2.75 |
| Day low | $3.36 | Volume | 337,600 |
| Day high | $3.49 | Avg. volume | 471,127 |
| 50-day MA | $3.26 | Dividend yield | N/A |
| 200-day MA | $3.54 | Market Cap | 284.64M |
AVIR Stock Price Chart Interactive Chart >
Atea Pharmaceuticals Inc. (AVIR) Company Bio
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
AVIR Price Returns
| 1-mo | 5.64% |
| 3-mo | -3.16% |
| 6-mo | -13.59% |
| 1-year | -6.91% |
| 3-year | -47.67% |
| 5-year | N/A |
| YTD | 0.60% |
| 2024 | 9.84% |
| 2023 | -36.59% |
| 2022 | -46.20% |
| 2021 | -78.60% |
| 2020 | N/A |
Loading social stream, please wait...